People with heart failure have long been advised to limit the amount of fluids they consume each day to help reduce congestion, or the buildup of fluid in the lungs and extremities, but that advice ...

Completing (or Continuing) Your Training? Let's Stay in Touch! During and just after your training, the right support is critical. Ensure we're providing you with support tailored to your needs. If ...

For more than 75 years, the ACC has been a trusted source of evidence-based cardiovascular guidance, delivering timely, actionable recommendations that support clinicians in providing optimal patient ...

As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to ...

Associate of the American College of Cardiology (AACC) is one of the most distinguished designations the College offers its members, honoring those with advanced training and education who have shown ...

The ACC Prevention of Cardiovascular Disease Section was created in March 2014 and emerged from the original ACC Prevention Committee when it became clear that cardiovascular disease (CVD) prevention, ...

A robust body of observational and Mendelian randomization data establishes a causal relationship between elevated Lp(a) and ASCVD, ischemic stroke and calcific aortic valve stenosis (CAVS). 3 A ...

According to the ACC/American Heart Association (AHA) guideline, all adults should undergo cholesterol screening to help assess long-term cardiovascular risk. 5,6 Serum LDL-C levels <100 mg/dL are ...

The following are key points to remember from the 2019 European Society of Cardiology (ESC) guidelines for the management of patients with supraventricular tachycardia (SVT): ...

The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated guideline for the management of dyslipidemia—abnormal ...

The following are key points to remember from a review of lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD): ...

The U.S. Food and Drug Administration (FDA) has approved baxdrostat, a first-in-class oral aldosterone synthase inhibitor, as an add-on therapy for hypertension in adults whose blood pressure (BP) is ...